海外の治験の状況「前立腺癌」での検索結果
22件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- Randomized phase II CAbazitaxel dose Individualization and Neutropenia prevention TriAl (CAINTA)
- Stage II with advanced Castration-Resistant Prostate Cancer (CRPC);Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, Germany, Switzerland
- 2014-06-03
Authorised
- MULTICENTRE, SINGLE-ARM, OPEN LABEL CLINICAL TRIAL INTENDED TO PROVIDE EARLY ACCESS TO CABAZITAXEL IN PATIENTS WITH METASTATIC HORMONE REFRACTORY PROSTATE CANCER PREVIOUSLY TREATED WITH A DOCETAXEL-CONTAINING REGIMEN AND TO DOCUMENT SAFETY OF CABAZITAXEL IN THESE PATIENTS
- Metastatic hormone refractory prostate cancer previously treated with a docetaxel-containing regimen MedDRA version: 14.1 Level: PT Classification code 10036909 Term: Prostate cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Austria, Canada, China, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Malaysia, Mexico, Philippines, Portugal, Singapore, Spain, Sweden, Taiwan, United Kingdom
- 2010-10-08